Allergan plc

Address:
Clonshaugh Business and Technology Park
Coolock, Dublin
D17 E400
Ireland

Allergan plc articles

Displaying 1 - 1 of 1

TrueTear granted marketing authorisation by the FDA

TrueTear granted marketing authorisation by the FDA
Allergan plc has announced that it has been granted marketing authorisation from the U.S. FDA for TrueTear Intranasal Tear Neurostimulator, the first and only FDA-cleared device developed to temporarily increase tear production during neurostimulation in adult patients. TrueTear is a handheld stimulator with daily disposable tips that is inserted into the nasal cavity to induce the production of tears.
26th April 2017


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

European Smart Homes 2017
25th October 2017
United Kingdom London
TU-Automotive Europe 2017
6th November 2017
Germany Munich
Productronica 2017
14th November 2017
Germany Messe Munchen
Future Armoured Vehicles Survivability 2017
14th November 2017
United Kingdom London
POWER & ENERGY 2017
22nd November 2017
Rwanda Kigali